aspartic acid has been researched along with Dermatoses in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bau, AE; de Zwart-Storm, EA; Foelster-Holst, R; Frank, J; Graziadio, C; Kamps, MA; Martin, PE; Paskulin, GA; Rosa, RF; van Geel, M; van Steensel, MA; Zen, PR | 1 |
VOLKOV, VP | 1 |
Christiani, DC; Gonzalez, E; Mahiuddin, G; McCarty, KM; Quamruzzaman, Q; Rahman, M; Ryan, L; Smith, TJ; Su, L; Zhou, W | 1 |
Bundy, B; Creasman, WT; Muss, HB; Slavik, M; Stehman, FB | 1 |
Benjamin, RS; Bodey, GP; Kurzrock, R; Papdopoulos, N; Plager, C; Valdivieso, M; Yap, BS | 1 |
Casper, ES; Gralla, RJ; Natale, RB; Yagoda, A; Young, CW | 1 |
6 other study(ies) available for aspartic acid and Dermatoses
Article | Year |
---|---|
Molecular analysis of connexin26 asparagine14 mutations associated with syndromic skin phenotypes.
Topics: Adult; Asparagine; Aspartic Acid; Cell Membrane; Child; Connexin 26; Connexins; Cytoplasm; Endoplasmic Reticulum; Female; Fluoresceins; Gap Junctions; Hearing Loss; HeLa Cells; Humans; Hypertrichosis; Keratoderma, Palmoplantar; Keratosis; Lysine; Male; Mutation, Missense; Nails, Malformed; Protein Transport; Skin; Skin Diseases; Syndrome; Transfection; Tyrosine | 2011 |
[FREE AMINO ACIDS IN THE BLOOD AND URINE OF PATIENTS WITH SOME FORMS OF DERMATOSIS].
Topics: Alanine; Amino Acids; Arginine; Aspartic Acid; Blood; Cystine; Dermatitis; Eczema; Erythema Multiforme; Glutamates; Glycine; Histidine; Lupus Erythematosus, Systemic; Lysine; Proteins; Psoriasis; Renal Aminoacidurias; Serine; Skin Diseases; Taurine; Threonine; Toxicology; Tryptophan; Urticaria | 1964 |
Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions.
Topics: Adult; Amino Acid Substitution; Arsenic; Asparagine; Aspartic Acid; Case-Control Studies; Female; Genetic Predisposition to Disease; Glutamine; Humans; Lysine; Male; Polymorphism, Single Nucleotide; Skin Diseases; Sunburn; Water Supply; Xeroderma Pigmentosum Group D Protein | 2007 |
A phase II study of PALA (NSC 224131) in patients with advanced ovarian carcinoma. A Gynecologic Oncology Group study.
Topics: Adult; Aged; Aspartic Acid; Blood Cell Count; Drug Evaluation; Female; Humans; Middle Aged; Neoplasm Metastasis; Organophosphorus Compounds; Ovarian Neoplasms; Phosphonoacetic Acid; Skin Diseases; Time Factors | 1984 |
Phase II evaluation of PALA in patients with refractory metastatic sarcomas.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Aspartic Acid; Bone Neoplasms; Diarrhea; Drug Evaluation; Female; Humans; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Sarcoma; Skin Diseases; Soft Tissue Neoplasms; Stomatitis | 1984 |
Phase I trial of PALA.
Topics: Antineoplastic Agents; Aspartic Acid; Brain Diseases; Diarrhea; Dose-Response Relationship, Drug; Gastrointestinal Diseases; Humans; Leukocyte Count; Neoplasms; Organophosphorus Compounds; Phosphonoacetic Acid; Platelet Count; Seizures; Skin Diseases | 1980 |